The Effect of a Vapor Barrier in Combination With Active External Rewarming for Patients With Accidental Hypothermia

Sponsor
Haukeland University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05779722
Collaborator
(none)
16
1
2
12.3
1.3

Study Details

Study Description

Brief Summary

Most guidelines recommend the use of a vapor barrier when wrapping and isolating hypothermic patients from the environment, and this is especially important if the patient is wearing wet clothing. The vapor barrier will contain moisture evaporated from the wet clothes of the patient and increase the humidity. Once the humidity levels reach 100%, the evaporation and thereby the evaporative heat loss will stop. The theory is that the addition of a vapor barrier will reduce the amount of heat loss and contribute to more efficient rewarming of wet, hypothermic patients. We aim to investigate how much more efficient a wrapping model with active external rewarming is with the addition of a vapor barrier.

Condition or Disease Intervention/Treatment Phase
  • Device: Vapor barrier
N/A

Detailed Description

The study will use a crossover design on where research participants will undergo repetitions of the same scenario with different interventions in order to serve as their own control. The research participants will be healthy volunteers providing both oral and written consent.

We intend to perform the experiments in an outdoor laboratory in order to achieve the most realistic conditions possible. The experiments will be conducted in Hemsedal, Norway in our "Mountain Lab", a climate chamber built inside a snow cave.

Before the start of the experiment, the research participants will be positioned in a supine position in the snow cave on an insulated stretcher in wet clothes saturated with a standardized amount of water.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The study will use a crossover design on where research participants will undergo repetitions of the same scenario with different interventions in order to serve as their own control. We intend to perform the experiments in an outdoor laboratory in order to achieve the most realistic conditions possible. The experiments will be conducted in Hemsedal, Norway in our "Mountain Lab", a climate chamber built inside a snow cave. Before the start of the experiment, the research participants will be positioned in a supine position in the snow cave on an insulated stretcher in wet clothes saturated with a standardized amount of water. They will stay in this position for 45 minutes to allow for a drop in the skin temperature without a drop in core body temperature. After 45 minutes, the research participant will be randomised into one of two scenarios, intervention or control.The study will use a crossover design on where research participants will undergo repetitions of the same scenario with different interventions in order to serve as their own control. We intend to perform the experiments in an outdoor laboratory in order to achieve the most realistic conditions possible. The experiments will be conducted in Hemsedal, Norway in our "Mountain Lab", a climate chamber built inside a snow cave. Before the start of the experiment, the research participants will be positioned in a supine position in the snow cave on an insulated stretcher in wet clothes saturated with a standardized amount of water. They will stay in this position for 45 minutes to allow for a drop in the skin temperature without a drop in core body temperature. After 45 minutes, the research participant will be randomised into one of two scenarios, intervention or control.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of a Vapor Barrier in Combination With Active External Rewarming for Patients
Actual Study Start Date :
Mar 8, 2023
Anticipated Primary Completion Date :
Mar 17, 2023
Anticipated Study Completion Date :
Mar 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

wrapping the participants in a vapor barrier as the inner layer (intervention),

Device: Vapor barrier
Vapor barrier

No Intervention: No intervention

without the vapor barrier to serve as a negative control

Outcome Measures

Primary Outcome Measures

  1. Skin temperature [45 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy volunteers
Exclusion Criteria:
  • any cronic sickness

Contacts and Locations

Locations

Site City State Country Postal Code
1 Haukeland University Hospital Bergen Norway

Sponsors and Collaborators

  • Haukeland University Hospital

Investigators

  • Study Director: Torbjørn Nedrebø, PhD, Research director

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Haukeland University Hospital
ClinicalTrials.gov Identifier:
NCT05779722
Other Study ID Numbers:
  • 566433
First Posted:
Mar 22, 2023
Last Update Posted:
Mar 22, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2023